Cargando…
Gene correction of HBB mutations in CD34(+) hematopoietic stem cells using Cas9 mRNA and ssODN donors
BACKGROUND: β-Thalassemia is an inherited hematological disorder caused by mutations in the human hemoglobin beta (HBB) gene that reduce or abrogate β-globin expression. Although lentiviral-mediated expression of β-globin and autologous transplantation is a promising therapeutic approach, the risk o...
Autores principales: | Antony, Justin S., Latifi, Ngadhnjim, Haque, A. K. M. Ashiqul, Lamsfus-Calle, Andrés, Daniel-Moreno, Alberto, Graeter, Sebastian, Baskaran, Praveen, Weinmann, Petra, Mezger, Markus, Handgretinger, Rupert, Kormann, Michael S. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6236008/ https://www.ncbi.nlm.nih.gov/pubmed/30430274 http://dx.doi.org/10.1186/s40348-018-0086-1 |
Ejemplares similares
-
Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34(+) HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
por: Lamsfus-Calle, Andrés, et al.
Publicado: (2020) -
Multiplex genomic structure variation mediated by TALEN and ssODN
por: Ma, Sanyuan, et al.
Publicado: (2014) -
Combinatorial gene editing in mammalian cells using ssODNs and TALENs
por: Strouse, Bryan, et al.
Publicado: (2014) -
ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes
por: Yoshimi, Kazuto, et al.
Publicado: (2016) -
Efficient In Vivo Introduction of Point Mutations Using ssODN and a Co-CRISPR Approach
por: Levi, Tgst, et al.
Publicado: (2020)